These results indicate that GMEB2 may promote CRC growth by enhancing the constitutive expression of proliferation-associated genes in the NF-κB pathway, such as cyclin D1, cyclin E and Myc [52]. This evidence concerns the gene NFKB1 and colorectal carcinoma.